Gilabert J

No ORCID on file · 11 papers in corpus · active 2003-2014

Study types

  • article 8
  • review 2
  • other 1

Condition tags

  • endometriosis 11
  • endometrioma 4
article 2014
MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors
Human Reproduction ·doi:10.1093/humrep/deu019

STUDY QUESTION: Could an aberrant microRNA (miRNA) expression profile be responsible for the changes in the angiogenic and fibrinolytic states observed in endometriotic lesions? SUMMARY ANSWER: This study revealed characteristic miRNA expre…

article 2013
Peritoneal Fluid Reduces Angiogenesis-Related MicroRNA Expression in Cell Cultures of Endometrial and Endometriotic Tissues from Women with Endometriosis
PloS one ·doi:10.1371/journal.pone.0062370

UNLABELLED: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent gynecological diseases. It has been suggested that modifications of both endometrial and peritoneal factors could be implicate…

article 2011
microRNAs expression in endometriosis and their relation to angiogenic factors
Human Reproduction ·doi:10.1093/humrep/der025

BACKGROUND: Endometriosis is a common, multifactorial disease in which angiogenesis may be involved in the growth of endometrium outside the uterus. microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and p…

article 2009
Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis
Human Reproduction ·doi:10.1093/humrep/dep419

BACKGROUND: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent benign gynaecological diseases. It has been suggested that both endometrial and peritoneal factors, related to angiogenesis an…

article 2008
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression
Thrombosis research ·doi:10.1016/j.thromres.2008.02.010

IntroductionEndometriosis is a benign gynecologic disease with a high prevalence. It is a multifactorial and polygenic entity in which the fibrinolytic system may be implicated. The objective of this study was to evaluate the plasminogen ac…

article 2008
Vascular endothelial growth factor polymorphisms (−460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.08.079

ObjectiveTo analyze three functional vascular endothelial growth factor (VEGF) polymorphisms (-460C/T, +405G/C, and 936C/T) in women with and without endometriosis and their correlation with VEGF expression in endometrial tissue and periton…

other 2007
Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems
Human Reproduction ·doi:10.1093/humrep/dem149

BACKGROUND: Endometriosis is a highly prevalent, benign disease in which the angiogenic, fibrinolytic and metalloproteinase (MMP) systems may be implicated. The objective of this study is to analyse mRNA expression and protein levels of sev…

review 2006
Expression of the fibrinolytic components in endometriosis
Pathophysiology of haemostasis and thrombosis ·doi:10.1159/000093556

Endometriosis is a benign gynaecologic disease defined as the presence of endometrial tissue outside the uterus. This tissue has the ability to implant at ectopic sites, such as ovary and peritoneum, where a local extracellular proteolysis …

review 2005
Plasminogen activators and plasminogen activator inhibitors in endometriosis
Frontiers in bioscience : a journal and virtual library ·doi:10.2741/1609

Endometriosis is one of the most frequent benign gynecological diseases that affect women. Little is known about the pathogenesis and etiology of endometriosis, despite the numerous studies performed in this field. Although endometriosis is…

article 2004
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT–PCR assay
Human Reproduction ·doi:10.1093/humrep/deh571

BACKGROUND: The plasminogen activator (PA) and matrix metalloproteinase (MMP) systems are implicated in the establishment of endometriosis. The mechanisms by which these systems are involved in the pathogenesis of this disease are not well …

article 2003
Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis
Human Reproduction ·doi:10.1093/humrep/deg300

BACKGROUND: Endometriosis is considered a benign disease that has the ability to invade normal tissue. As in neoplastic growth, local extracellular proteolysis may take place. The aim of this study is to analyse several components of the pl…